ABCC10 and cancer: Despite the efflux of the specific substrates being decreased in PD173074-treated cancer cells, the expression of the aforementioned ABC transporters remained constant, thereby suggesting the ability of this TKI to impair the function of P-gp and MRP7 [208,209].